Division of Nephrology

Vaughn W. Folkert, M.D.

  1. Michael B, Coyne DW, Fishbane S, Folkert VW, Lynn R, Nissenson AR, agarwal R, Eschbach JW, Fadem SZ, Trout JR, Strobos J, Warnock DG. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran. Kidney Int. 61:1830-1839. 2002.
  2. Folkert VW, Javier AM, O’Mara NB. Caring for the renal failure patient: optimizing iron therapy. Nephrol Nurs J. 29:585-593. 2002.
  3. Coyne DW, Adkinson NF, Nissenson AR, Fishbane S, Agarwal R, Eschbach JW, Michael B, Folkert VW, Battle D, Trout JR, Dahl N, Myirski P, Strobos J, Warnock, DG. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients. Kidney Int. 63:217-224. 2003.
  4. Folkert VW, Michael B, Agarwal R, Coyne DW, Dahl N, Myirski P, Warnock DG. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher- dose (≥250 mg) administration. Am J Kidney Dis. 41:651-657. 2003
  5. Folkert, VW. Intravenous iron therapy in chronic kidney disease and peritoneal dialysis patients. Nephrol Nurs J. 30:571-576. 2003.
  6. Michael B, Coyne DW, Folkert VW, Dahl NV Warnock DG. Sodium ferric fluconate complex in haemodialysis patients: a prospective evaluation of long-term safety. Nephrol Dial Transplant. 19:1576-1580. 2004.

Interim Division Chief

Vaughn Folkert, M.D (bio)

Professor of Clinical Medicine 

 
 

Contact Us

Albert Einstein College of Medicine
615, Ullmann Building
1300 Morris Park Avenue
Bronx, Ny 10461

Phone: 718.430.3158
Click here to log in